Clinical trial
Specified Drug-use Survey of Fomepizole Intravenous Infusion "Takeda" (All-case Surveillance)
NCT02415712 is registered in ClinicalTrials.gov with Takeda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Specified Drug-use Survey of Fomepizole Intravenous Infusion "Takeda" (All-case Surveillance)
- Lead sponsor
- Takeda
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 27, 2015
- Completion date
- June 30, 2022
- Enrollment
- 147 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
ethylene glycol poisoning, methanol poisoning